Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.

已取消 10 由 Laba 发布于 2026/6/4 15:02:47

DOI:10.1056/NEJMoa2605555
作者：Eileen M O'Reilly,?Zev A Wainberg,?Andrew E Hendifar,?Mitesh J Borad,?Filippo Pietrantonio,?Shubham Pant,?Pascal Hammel,?Chiara Cremolini,?Gulam A Manji,?Paul E Oberstein,?Ignacio Garrido-Laguna,?Chri
文献类型：期刊论文
补充材料：只需要正文

New England Journal of Medicine (NEJM)

Abstract：Background: Current therapies offer limited benefit for patients with previously treated metastatic pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is the ke

应助信息

2026-06-04

Book学术机器人

2026/6/4 15:02:48 未找到该文献，机器人已退出，请等待人工下载

2026/6/4 15:02:47 Book学术AI机器人收到请求，开始寻找文献

2026/6/4 15:02:47 已向机器人发送请求

2026-06-04

Laba 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:知网种蛋部分物理性状对樱桃谷鸭孵化率的影响